Suggestions
Brian Corrigan
Senior Vice President, Regulatory Policy at Greenleaf Health LLC
Professional Background
Brian Corrigan is a highly accomplished professional with extensive experience in regulatory policy and government affairs, specifically within the healthcare and pharmaceutical industries. He currently serves as the Senior Vice President of Regulatory Policy at Greenleaf Health, Inc., where he plays a crucial role in shaping and navigating the complex regulatory landscape that impacts healthcare innovation and patient access to new therapies. Brian's expertise in policy development and stakeholder engagement has made him a valued leader in the field.
Before advancing to his current position, Brian held the role of Vice President of Regulatory Policy at Greenleaf Health, Inc., where he was instrumental in developing strategies that support clients in achieving successful regulatory outcomes. His journey in the pharmaceutical sector began at Vertex Pharmaceuticals, where he spent several years in various capacities, including Associate Director and Manager of Government Affairs & Public Policy. During his tenure at Vertex, Brian demonstrated his ability to cultivate relationships with government officials and advocate effectively for policy changes that benefit both the company and patients.
Additionally, Brian's career includes significant experience at Astellas Pharma, where he served as a Senior Federal Affairs & Policy Specialist. In this role, he directed initiatives aimed at influencing federal policies that affect the pharmaceutical industry. His time at ML Strategies, LLC, as a Manager of Government Relations, further honed his skills in navigating the intersections of healthcare, law, and policy. Brian began his professional journey as a Project Analyst at Mintz Levin, where he contributed to various legal and regulatory projects.
Education and Achievements
Brian Corrigan’s educational foundation was laid at Boston College, where he earned his Bachelor of Arts degree in History. This strong background in history has informed Brian's understanding of policy development and its impacts over time, allowing him to anticipate regulatory trends and contribute meaningfully to conversations surrounding healthcare policies. He further sharpened his analytical and legal skills by obtaining a Juris Doctor (JD) degree from George Mason University School of Law. His legal education has equipped him with a comprehensive understanding of the legislative processes that shape the healthcare landscape.
Throughout his career, Brian has been recognized for his ability to build coalitions and partnerships that advance innovative healthcare solutions. His work in regulatory policy positions him as a thought leader in crafting strategies that align regulatory expectations with clinical advancements. Brian's strong commitment to improving patient access to medications has been a consistent theme in his career, influencing the trajectory of his professional pursuits.
Achievements
Brian Corrigan’s career is marked by a series of notable achievements that reflect his deep expertise and strong commitment to healthcare regulatory policy. As Senior Vice President at Greenleaf Health, Inc., he has successfully led initiatives that support health innovation while ensuring compliance with evolving regulations. His leadership has not only benefitted the organizations he has represented but has also contributed positively to public health outcomes.
In his previous roles, notably at Vertex Pharmaceuticals, Brian played a key role in advocating for policies that promote research and development in the pharmaceutical space. His ability to leverage data-driven insights to inform legislative discussions has positioned him as a credible voice in the regulatory community. Brian’s collaborative efforts across various sectors have yielded successful outcomes in navigating complex regulatory environments, proving his effectiveness in leadership and strategic planning.
tags':['regulatory policy','government affairs','healthcare regulatory','pharmaceutical policy','Greenleaf Health','Vertex Pharmaceuticals','Astellas Pharma','Boston College','George Mason University','public policy','healthcare innovation','stakeholder engagement','legal education','policy advocacy','coalition building','FDA regulations','healthcare access','government relations','law career','history education','clinical advancements','therapeutic development'],
